MOGAT2: Key Enzyme in Fatty Acid Oxidation (G80168)

Target Name: MOGAT2

NCBI ID: G80168

MOGAT2

MOGAT2: Key Enzyme in Fatty Acid Oxidation

MOGAT2 (acyl-CoA:monoacylglycerol acyltransferase 2) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and liver. It is a key enzyme in the fatty acid oxidation pathway, which is a critical pathway for the production of energy from fatty acids. MOGAT2 plays a crucial role in the production of fatty acids from the acyl-CoA, which is a key intermediate step in the fatty acid oxidation pathway.

MOGAT2 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and liver. It is a key enzyme in the fatty acid oxidation pathway, which is a critical pathway for the production of energy from fatty acids. MOGAT2 plays a crucial role in the production of fatty acids from the acyl-CoA, which is a key intermediate step in the fatty acid oxidation pathway.

One of the key functions of MOGAT2 is its role in the production of fatty acids from the acyl-CoA. Acyl-CoA is a key intermediate step in the fatty acid oxidation pathway, and it is produced from the 尾-hydroxy-acyl-CoA (尾-hydroxy-acetyl-CoA), which is produced from the 尾-hydroxy-CoA, which is produced from the acetyl-CoA. MOGAT2 is involved in the production of 尾-hydroxy-acetyl-CoA from 尾-hydroxy-acyl-CoA.

MOGAT2 is also involved in the production of fatty acids from the 尾-hydroxy-acetyl-CoA. 尾-hydroxy-acetyl-CoA is a key intermediate step in the fatty acid oxidation pathway and is produced from the 尾-hydroxy-CoA, which is produced from the acetyl-CoA. MOGAT2 is involved in the production of 尾-hydroxy-acetyl-CoA from 尾-hydroxy-CoA.

MOGAT2 is also involved in the metabolism of fatty acids. It is a key enzyme in the fatty acid oxidation pathway, which is responsible for the production of fatty acids from the acyl-CoA. MOGAT2 is involved in the production of fatty acids from the acyl-CoA, which is a key intermediate step in the fatty acid oxidation pathway.

MOGAT2 is also involved in the regulation of fatty acid oxidation. It is a key enzyme in the fatty acid oxidation pathway, which is responsible for the production of fatty acids from the acyl-CoA. MOGAT2 plays a crucial role in the regulation of fatty acid oxidation by producing 尾-hydroxy-acetyl-CoA, which is a key intermediate step in the fatty acid oxidation pathway.

MOGAT2 is also involved in the regulation of cellular metabolism. It is a key enzyme in the fatty acid oxidation pathway, which is responsible for the production of fatty acids from the acyl-CoA. MOGAT2 plays a crucial role in the regulation of cellular metabolism by producing 尾-hydroxy-acetyl-CoA, which is a key intermediate step in the fatty acid oxidation pathway.

MOGAT2 is also involved in the regulation of inflammation. It is a key enzyme in the fatty acid oxidation pathway, which is responsible for the production of fatty acids from the acyl-CoA. MOGAT2 plays a crucial role in the regulation of inflammation by producing fatty acids, which can contribute to inflammation.

MOGAT2 is also involved in the regulation of cellular signaling. It is a key enzyme in the fatty acid oxidation pathway, which is responsible for the production of fatty acids from the acyl-CoA. MOGAT2 plays

Protein Name: Monoacylglycerol O-acyltransferase 2

Functions: Catalyzes the formation of diacylglycerol from 2-monoacylglycerol and fatty acyl-CoA. Has a preference toward monoacylglycerols containing unsaturated fatty acids in an order of C18:3 > C18:2 > C18:1 > C18:0. Plays a central role in absorption of dietary fat in the small intestine by catalyzing the resynthesis of triacylglycerol in enterocytes. May play a role in diet-induced obesity. Also able to use 1-monoalkylglycerol (1-MAkG) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG) (PubMed:28420705)

The "MOGAT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MOGAT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets